180 related articles for article (PubMed ID: 25115869)
21. The Design and Preclinical Evaluation of a Single-Label Bimodal Nanobody Tracer for Image-Guided Surgery.
Debie P; Declerck NB; van Willigen D; Huygen CM; De Sloovere B; Mateusiak L; Bridoux J; Puttemans J; Devoogdt N; van Leeuwen FWB; Hernot S
Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33652977
[TBL] [Abstract][Full Text] [Related]
22. Dual labeling of lipopolysaccharides for SPECT-CT imaging and fluorescence microscopy.
Duheron V; Moreau M; Collin B; Sali W; Bernhard C; Goze C; Gautier T; Pais de Barros JP; Deckert V; Brunotte F; Lagrost L; Denat F
ACS Chem Biol; 2014 Mar; 9(3):656-62. PubMed ID: 24328371
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory bowel disease: MR- and SPECT/CT-based macrophage imaging for monitoring and evaluating disease activity in experimental mouse model--pilot study.
Wu Y; Briley-Saebo K; Xie J; Zhang R; Wang Z; He C; Tang CY; Tao X
Radiology; 2014 May; 271(2):400-7. PubMed ID: 24475849
[TBL] [Abstract][Full Text] [Related]
24. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
[TBL] [Abstract][Full Text] [Related]
25. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
Müller C; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
[TBL] [Abstract][Full Text] [Related]
26. Multimodal Molecular Imaging Reveals High Target Uptake and Specificity of 111In- and 68Ga-Labeled Fibrin-Binding Probes for Thrombus Detection in Rats.
Oliveira BL; Blasi F; Rietz TA; Rotile NJ; Day H; Caravan P
J Nucl Med; 2015 Oct; 56(10):1587-92. PubMed ID: 26251420
[TBL] [Abstract][Full Text] [Related]
27. Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer.
Sampath L; Kwon S; Ke S; Wang W; Schiff R; Mawad ME; Sevick-Muraca EM
J Nucl Med; 2007 Sep; 48(9):1501-10. PubMed ID: 17785729
[TBL] [Abstract][Full Text] [Related]
28. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
29. Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using
de Gooyer JM; Elekonawo FMK; Bos DL; van der Post RS; Pèlegrin A; Framery B; Cailler F; Vahrmeijer AL; de Wilt JHW; Rijpkema M
Clin Cancer Res; 2020 Nov; 26(22):5934-5942. PubMed ID: 32900795
[TBL] [Abstract][Full Text] [Related]
30. Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours.
Debie P; Lafont C; Defrise M; Hansen I; van Willigen DM; van Leeuwen FWB; Gijsbers R; D'Huyvetter M; Devoogdt N; Lahoutte T; Mollard P; Hernot S
J Control Release; 2020 Jan; 317():34-42. PubMed ID: 31734445
[TBL] [Abstract][Full Text] [Related]
31. Zinc(II)-coordinated oligotyrosine: a new class of cell penetrating peptide.
Johnson JR; Jiang H; Smith BD
Bioconjug Chem; 2008 May; 19(5):1033-9. PubMed ID: 18399623
[TBL] [Abstract][Full Text] [Related]
32. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo.
Kennel SJ; Woodward JD; Rondinone AJ; Wall J; Huang Y; Mirzadeh S
Nucl Med Biol; 2008 May; 35(4):501-14. PubMed ID: 18482688
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous acquisition of (99m)Tc- and (123)I-labeled radiotracers using a preclinical SPECT scanner with CZT detectors.
Kobayashi M; Matsunari I; Nishi K; Mizutani A; Miyazaki Y; Ogai K; Sugama J; Shiba K; Kawai K; Kinuya S
Ann Nucl Med; 2016 May; 30(4):263-71. PubMed ID: 26747655
[TBL] [Abstract][Full Text] [Related]
34. Hybrid Tracers Based on Cyanine Backbones Targeting Prostate-Specific Membrane Antigen: Tuning Pharmacokinetic Properties and Exploring Dye-Protein Interaction.
Hensbergen AW; Buckle T; van Willigen DM; Schottelius M; Welling MM; van der Wijk FA; Maurer T; van der Poel HG; van der Pluijm G; van Weerden WM; Wester HJ; van Leeuwen FWB
J Nucl Med; 2020 Feb; 61(2):234-241. PubMed ID: 31481575
[TBL] [Abstract][Full Text] [Related]
35. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry.
Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H
Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201
[TBL] [Abstract][Full Text] [Related]
36. SPECT- and fluorescence image-guided surgery using a dual-labeled carcinoembryonic antigen-targeting antibody.
Rijpkema M; Oyen WJ; Bos D; Franssen GM; Goldenberg DM; Boerman OC
J Nucl Med; 2014 Sep; 55(9):1519-24. PubMed ID: 24982436
[TBL] [Abstract][Full Text] [Related]
37. Library synthesis, screening, and discovery of modified Zinc(II)-Bis(dipicolylamine) probe for enhanced molecular imaging of cell death.
Plaunt AJ; Harmatys KM; Wolter WR; Suckow MA; Smith BD
Bioconjug Chem; 2014 Apr; 25(4):724-37. PubMed ID: 24575875
[TBL] [Abstract][Full Text] [Related]
38. Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging.
Briat A; Wenk CH; Ahmadi M; Claron M; Boturyn D; Josserand V; Dumy P; Fagret D; Coll JL; Ghezzi C; Sancey L; Vuillez JP
Cancer Sci; 2012 Jun; 103(6):1105-10. PubMed ID: 22448775
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of 111In-labeled EPep and FibPep as tracers for fibrin SPECT imaging.
Starmans LW; van Duijnhoven SM; Rossin R; Berben M; Aime S; Daemen MJ; Nicolay K; Grüll H
Mol Pharm; 2013 Nov; 10(11):4309-21. PubMed ID: 24099178
[TBL] [Abstract][Full Text] [Related]
40. 203Pb-labeled alpha-melanocyte-stimulating hormone peptide as an imaging probe for melanoma detection.
Miao Y; Figueroa SD; Fisher DR; Moore HA; Testa RF; Hoffman TJ; Quinn TP
J Nucl Med; 2008 May; 49(5):823-9. PubMed ID: 18413404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
